EU Fails to Find United Response to AstraZeneca Vaccine Risk (1)

April 8, 2021, 7:03 AM

The European Union failed to form a united response to links between AstraZeneca Plc’s Covid-19 vaccine and a rare type of blood clotting, missing an opportunity to inject momentum into the bloc’s sluggish inoculation program.

At a meeting that ran until late Wednesday, EU health ministers promised to continue discussions on vaccination planning and process. Health Commissioner Stella Kyriakides had called on the bloc’s governments to forge a coordinated strategy, saying it “will be key for us to speak with one voice.” The EU needs “an approach which does not confuse citizens and that does not fuel vaccine hesitancy,”...

To read the full article log in.

Learn more about a Bloomberg Law subscription.